Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1059P (RNA, U6 small nuclear 1059, pseudogene) is a pseudogene related to the U6 small nuclear RNA family[1]. U6 small nuclear RNAs (snRNAs) are essential non-coding RNAs involved in the catalysis of pre-mRNA splicing as a core spliceosomal component[3][5]. However, RNU6-1059P is a pseudogene, meaning it is a non-functional genetic element that has lost its ability to produce a functional RNA or protein product, generally through accumulated mutations[1][6]. While active U6 snRNA is highly conserved and essential for spliceosome activity, pseudogenes such as RNU6-1059P are generally considered non-functional and are not targets for therapeutic intervention nor do they code for receptors, enzymes, or other conventional drug targets[1][6]. Recent research suggests some pseudogenes can play indirect roles in gene regulation, for example by acting as miRNA sponges, but no specific functional, disease, or biomarker role is established or reported for RNU6-1059P[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1059, pseudogene (RNU6-1059P).